There are 3387 resources available
1209MO - Computer-aided HCC lesion detection based on deep learning and CT images
Presenter: Oliver Lucidarme
Session: Mini oral session - Basic science & translational research
Resources:
Abstract
Slides
Webcast
1182O - Temozolomide treatment induces an MMR-dependent hypermutator phenotype in well differentiated pancreatic neuroendocrine tumors
Presenter: Louis de Mestier du Bourg
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
1321MO - Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2 (ERBB2)-mutant (HER2m) metastatic non–small cell lung cancer (NSCLC) with and without brain metastases (BMs): Pooled analyses from DESTINY-Lung01 and DESTINY-Lung02
Presenter: David Planchard
Session: Mini oral session 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Conclusions and perspectives
Presenter: Melvin Lee Kiang Chua
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast
Invited Discussant 382MO, 383MO and 384MO
Presenter: Christoph Thomssen
Session: Mini oral session - Breast cancer, metastatic
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Clara Montagut Viladot
Session: Circulating tumour DNA: A perfect fit?
Resources:
Slides
Webcast
LBA90 - A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIO-STS-0415)
Presenter: Viktor Gruenwald
Session: Proffered Paper session - Sarcoma
Resources:
Abstract
Slides
Webcast
655O - Phase Ib study of cofetuzumab pelidotin, an anti-PTK7 antibody-drug conjugate, in patients with PTK7-expressing recurrent non-small cell lung cancer (rNSCLC)
Presenter: Melissa Johnson
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
LBA85 - Niraparib (NIRA) with abiraterone acetate plus prednisone (AAP) as first-line (1L) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: Three-year update and final analysis (FA) of MAGNITUDE
Presenter: Kim Nguyen Chi
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
1210MO - Comparison of clinical and radiological features-based and radiomics features-based models for pulmonary nodule malignancy prediction on CT images
Presenter: Fanrui Zeng
Session: Mini oral session - Basic science & translational research
Resources:
Abstract
Slides
Webcast